U.S. FDA Grants Breakthrough Device Designation to Vascular Perfusion Solutions for its Visionary VP.S Encore™ Cardiac Transport Device
Vascular Perfusion Solutions commercialise oxygenated perfusion, preservation, and resuscitation solutions
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Feb 21
Vascular Perfusion Solutions commercialise oxygenated perfusion, preservation, and resuscitation solutions
02 Feb 21
Researchers from Harvard Medical School and Massachussets General Hospital may have laid the foundation for better cardiovascular risk…
01 Feb 21
The study demonstrated no incidences of structural valve deterioration at the five-year review mark
29 Jan 21
Epi+Gen CHD test will help sensitively evaluate the risk for the onset of new coronary heart disease
29 Jan 21
The trial will assess efficacy of AccuCinch system in patients who have symptomatic heart failure with a reduced…
26 Jan 21
The company intends to utilise the proceeds to boost commercial growth of the Globe system across Europe
22 Jan 21
Sky Medical Technology's head of product research and development explains the journey geko has taken in pursuit of…
22 Jan 21
Preventice provides a portfolio of mobile cardiac health solutions and services
12 Jan 21
The advanced wearable device is designed to continuously collect ECG data via dry lead electrodes
11 Jan 21
Avidity has entered into a research collaboration with MyoKardia to leverage its genetic cardiomyopathy platform including, among other…